Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
3.
4.

The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.

Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG.

Diabetes Care. 1997 Jun;20(6):913-21.

PMID:
9167099
5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
8.

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM.

Ann Intern Med. 1994 Dec 15;121(12):928-35.

PMID:
7734015
9.

Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients.

Trovati M, Carta Q, Cavalot F, Vitali S, Banaudi C, Lucchina PG, Fiocchi F, Emanuelli G, Lenti G.

Diabetes Care. 1984 Sep-Oct;7(5):416-20.

PMID:
6389056
10.

Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients.

Ligtenberg PC, Hoekstra JB, Bol E, Zonderland ML, Erkelens DW.

Clin Sci (Lond). 1997 Aug;93(2):127-35.

PMID:
9301427
12.

Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA.

Diabet Med. 2001 Jan;18(1):10-6.

PMID:
11168335
13.

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

Diabetes Care. 2000 Aug;23(8):1154-61.

14.

The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.

Ak G, Buyukberber S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A.

J Diabetes Complications. 2001 May-Jun;15(3):150-7.

PMID:
11358684
15.

Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes.

Herz M, Profozic V, Arora V, Smircic-Duvnjak L, Kovacevic I, Boras J, Campaigne BN, Metelko Z.

Curr Med Res Opin. 2002;18(4):188-93.

PMID:
12201618
17.

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.

PMID:
9589227
18.

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

Clin Ther. 2001 Oct;23(10):1732-44.

PMID:
11726007
19.

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI.

Ann Intern Med. 1998 Feb 1;128(3):176-85.

PMID:
9454525
20.

Supplemental Content

Support Center